From: Reliability of dynamic susceptibility contrast perfusion metrics in pre- and post-treatment glioma
 | Perfusion metric | Intraclass Correlation | 95%-Confidence interval | P-value | |
---|---|---|---|---|---|
Lower Bound | Upper Bound | ||||
Whole tumor region; Untreated group of patients; Circular ROI | CBF | 0.963 | 0.924 | 0.984 |  < 0.001 |
CBV | 0.948 | 0.892 | 0.977 |  < 0.001 | |
TTP | 0.951 | 0.899 | 0.979 |  < 0.001 | |
Tumor hotspot; Untreated group of patients; Circular ROI | CBF | 0.441 | -0.156 | 0.756 | 0.058 |
CBV | 0.501 | -0.032 | 0.782 | 0.030 | |
TTP | 0.198 | -0.658 | 0.649 | 0.269 | |
Peritumoral region; Untreated group of patients; Circular ROI | CBF | 0.821 | 0.630 | 0.922 |  < 0.001 |
CBV | 0.924 | 0.843 | 0.967 |  < 0.001 | |
TTP | 0.741 | 0.465 | 0.887 |  < 0.001 | |
Whole tumor region; Untreated group of patients;Polygonal ROI | CBF | 0.504 | -0.026 | 0.783 | 0.029 |
CBV | 0.687 | 0.352 | 0.863 | 0.001 | |
TTP | 0.856 | 0.703 | 0.937 |  < 0.001 | |
Tumor hotspot; Untreated group of patients; Polygonal ROI | CBF | 0.828 | 0.644 | 0.925 |  < 0.001 |
CBV | 0.529 | 0.027 | 0.794 | 0.021 | |
TTP | 0.200 | -0.655 | 0.650 | 0.268 | |
Peritumoral region; Untreated group of patients; Polygonal ROI | CBF | 0.442 | -0.154 | 0.756 | 0.057 |
CBV | 0.409 | -0.223 | 0.742 | 0.078 | |
TTP | 0.113 | -0.834 | 0.612 | 0.363 |